Impact of protocol change on individual factors related to course of adverse reactions to chemotherapy for breast cancer.
Daniela Polessa PaulaVanessa I do Brasil CostaRosane V JorgeFlávio F NobrePublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2019)
The results suggest the need for monitoring non-hematological reactions during the docetaxel phase of FAC-D treatment. The factors related to more severe reactions depend on the chemotherapy protocol used.